Navigation Links
MGuard(TM) Coronary Stent System Approved in Israel
Date:12/8/2008

TEL AVIV, Israel, December 8 /PRNewswire/ -- InspireMD, Ltd. announced that the MGuard(TM) coronary stent system has been approved for use in Israel by the Israeli Ministry of Health.

The MGuard(TM) stent system presents a novel combination of a coronary stent merged with an embolic protection device. Lifelong embolic protection is achieved by an expandable, flexible fishnet style, micron level knit sleeve that wraps the stent. In addition, MGuard(TM) blocks embolic showers and plaque detachment from the arterial wall, blocking debris at the source during and post procedure. The net is designed to diffuse stent pressure on the vessel wall, thereby reducing injury and lowering the likelihood of restenosis. Since MGuard(TM) received CE Mark approval in November 2007 the product has been met with much enthusiasm and celebrated by leading interventional cardiologists worldwide. "We are very excited about MGuard(TM) being approved for use in Israel so soon" stated Dr. Asher Holzer, InspireMD's President. "Our leading Israeli Interventional Cardiologists have been eager to have this life saving stent system available at their hospitals and already in the few days since the local approval, lives of Israelis have been saved with MGuard(TM)". MGuard's relatively early regulatory approval in Israel may have been partly due to numerous recommendations by local opinion leaders to the Ministry of Health.

InspireMD will celebrate the launch of MGuard(TM) in Israel at the upcoming ICI '08 Meeting in Tel-Aviv, December 8th-9th where MGuard(TM) will be demonstrated at booth #18. In addition, InspireMD will be hosting an inspiring cocktail reception symposium on December 8th at the ICI Meeting, MGuard(TM): A Unique Solution for Managing Embolic Complications in Acute MI and SVG. Martin Leon MD and Chaim Lotan MD will chair the meeting where additional speakers include key world renowned interventional cardiologists Martin Rothma
'/>"/>

SOURCE InspireMD, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
2. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
3. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
4. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
5. Surgery More Likely Than Angioplasty to Relieve Pain for Patients With Coronary Artery Disease
6. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
7. Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
8. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
9. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
10. CorNova Preclinical Results of Valecor Platinum(TM) Coronary Stent Studies Presented at TCT 2007 Conference
11. VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...D, Mass., Dec. 3 MicroCHIPS, a dev... today announced it has been named a 2010 Technolo...e company was selected for pioneering a novel medi... implants designed to bridge the gap between disea...gies have broad applicability, from ,rescue, appli...
(Date:12/3/2009)...BURG, Pa., Dec. 3 New s...rocessing company build a new cold storage facilit...or expand operations while creating at least 20 jo..., The Pennsylvania Industrial Development Author...three projects. The investments, in the form of lo...
(Date:12/3/2009)... NANJING, China, Dec. 3 /PRNewswire-Asia/ -- Sim...ny") (NYSE: SCR ), a leading pharmaceutical comp..., and marketing of branded,generic and proprietary...na,s,State Food and Drug Administration ("SFDA") h...ality issues regarding human use rabies vaccine (v...
Breaking Medicine Technology:MicroCHIPS Named 2010 Technology Pioneer by World Economic Forum 2Governor Rendell: New State Investments Bear Fruit in Adams County; Help Pharmaceutical Company Expand in Philadelphia 2Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 2Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 3Research Based Biopharmaceutical Company Awards Trials to DATATRAK 4891 1Research Based Biopharmaceutical Company Awards Trials to DATATRAK 4891 2Research Based Biopharmaceutical Company Awards Trials to DATATRAK 4891 3Delcath Systems Inc Announces Patient Recruitment Exceeds 90 25 55233 1Delcath Systems Inc Announces Patient Recruitment Exceeds 90 25 55233 2Delcath Systems Inc Announces Patient Recruitment Exceeds 90 25 55233 3Vtech 28R 29 Delivers Todays Hottest Trends to Tech Savvy Kids 4890 1Vtech 28R 29 Delivers Todays Hottest Trends to Tech Savvy Kids 4890 2Vtech 28R 29 Delivers Todays Hottest Trends to Tech Savvy Kids 4890 3Vtech 28R 29 Delivers Todays Hottest Trends to Tech Savvy Kids 4890 4
(Date:12/3/2009)...ood, wing shapes changed rapidly, researchers say ... Many people think evolution takes hundreds, if no...er and new research shows exactly how: The simple ...g an effect on a population of birds. , Resear...ine edition of Current Biology , said a single po...
(Date:12/3/2009)... 3 According to the World Health O...Swine Flu") has reached a pandemic level. Over 50...least 6,500 fatalities. Since there is no longer ... these numbers undoubtedly understate the real sit...gi-bin/prnh/20091203/NY20654 ) ,, There are cu...
(Date:12/3/2009)..., PARSIPPANY, N.J. and ANDOVER, Mass., Dec. 3 /PRN...mage Intelligence® company, and Visage Imagin...icus Ltd. (ASX: PME) announced today that they hav...d market advanced oncology solutions for the clini...nership enables Definiens to utilize the Visage...
(Date:12/3/2009)...PRNewswire/ -- An exciting treatment gaining accep...latelet-rich plasma therapy (PRP), is showing stro...lant procedures, according to a prominent dental r...ntology . ,, James Rutkowski, DMD, PhD, repor... American Academy of Implant Dentistry that platel...
(Date:12/3/2009)...1,500 Jobs Listed through APHA,s Public Health Car...SNewswire/ -- Today,s White House jobs summit refl... professions, including public health. One public ...t job seekers to more than 1,500 jobs in the healt.../www.apha.org/about/careers/ is a full online car...
Breaking Medicine News(10 mins):Health News:Feeding Birds in Winter Could Speed Evolution of Species 2Health News:Buchang Global Health Forum 2009: An Innovative Approach for Management of H1N1 Swine Flu 2Health News:Visage Imaging and Definiens Announce Partnership 2Health News:Visage Imaging and Definiens Announce Partnership 3Health News:Platelet-rich Plasma Enhances Bone and Tissue Growth for Dental Implants 2Health News:Public Health Jobs Site Available to Help Meet Growing Demand 2
...ding to researchers at the University of Vermont i...ntain a balance between over inflation and under i... pumped in to the lungs then it will result in the...tect against VILI. But low tidal volumes can lead ...
...nd AIDS infections have shown a sharp rise in Jamm... have shot up from two in 1999 to 745 now, reports...ies in a low prevalence risk zone, with an infecti...ons of migrant labourers, truck drivers, security ...
...esearchers of the University of Queensland carried...ital in Brisbane. They reported that Spray –on ski... victims. “Microskin” is the product that not...spray-on skin technology, adheres to the epidermis...
...o probe has been developed by Georgia Tech researc...lls communicates with other cells and reacts //to ...ng it. This would help to better create drugs that...suffer from significant deficiencies. Typically, t...
...ease called Onchocerciasis, river blindness or cra...ea. The disease presents as a weakening// in affec...ot fit for work. This in turn adversely impacts th...viromental conditions such as humidity, rapid wate...
...dy published by scientists from California Univers... treatment needs re-evaluation//. Scientist have ...iretroviral therapy (ARV) by hiding in intestinal ...king. Professor Satya Dandekar, head of the...
Other Medicine News:Health News:Too Much of Air in the Lungs Results in VILI 2Health News:Too Much of Air in the Lungs Results in VILI 3Health News:Too Much of Air in the Lungs Results in VILI 4Health News:HIV/AIDS on Rise in Jammu and Kashmir 2Health News:Cell Behavior Better Understood with Nano Probe 2Health News:Cell Behavior Better Understood with Nano Probe 3Health News:Onchocerciasis: Presentation And Treatment 2
M2a-Taper RingLoc Liner
Ascent Primary Knee System - Ascent/Maxim CoCr I-Beam Tibial Tray
...nee offers a femoral option and tibial insert whic...gages at 60 degrees of flexion to induce a smooth ...degrees of flexion. Femoral component comes in a P...e constrained tibial insert in conjunction with th...
ADVANCE Posterior Stabilized Total Knee Systems
Medicine Products: